www.senology.org   -   Newsletter

"Join  the international senologic and oncologic  scientific community"

Gian Paolo Andreoletti, MD, Editor-in-Chief  -  paolo.andreoletti@senology.it

  Subscribe      Unsubscribe     Contact      Back Issues      www.senology.org / www.senology.it  Home Page

Literature Selection

Comments

  • "Direct MR galactography is a feasible tool to work up nipple discharge" - Siegfried A. Schwab, Department of Radiology, Universität Erlangen-Nürnberg, German
     
    "The feasibility of direct magnetic resonance galactography (dMRG) with intraductal contrast material injection was evaluated. 23 women with pathologic nipple discharge and pathologic conventional galactographic findings underwent physical examination, ultrasonography, and MR imaging before surgery. Besides the standard magnetic resonance mammography protocol additional high 3D-T1 and 3D-T2 MRG sequences were performed before (indirect magnetic resonance galactography, iMRG) and after (dMRG) gadolinium DTPA was injected into the discharging duct. MR findings were analyzed and compared to conventional galactography and histological reports. (....). We oncluded that direct magnetic resonance galactography  is feasible and may serve as an alternative to conventional galactography in the diagnostic work-up of pathologic nipple discharge. Compared to conventional galactography and standard breast MRI sequences, direct magnetic resonance galactography may provide additional diagnostic information"
    (Comment on:  Schwab SA et al.: "Direct MR galactography: feasibility study.", Radiology. 2008 Oct;249(1):54-61)

     

  • "Nonsteroidal anti-inflammatory drugs use is associated with reduced risk for breast cancer" - Bahi Takkouche, Department of of Preventive Medicine, University of Santiago de Compostela, Spain
     
    "The conclusions of our study are globally that regular use of any nonsteroidal anti-inflammatory drug (NSAID) is associated with a relative risk reduction for breast cancer of 12 percent  compared with non-users. A separate analysis for aspirin shows a 13 percent relative risk reduction, and an analysis for ibuprofen showed  a 21 percent relative reduction in risk for breast cancer. However, this does not mean  that we recommend the use of NSAIDs as a preventive measure as these  drugs may cause gastrointestinal bleeding"
    (Comment on:  Takkouche B and al.: "Breast Cancer and Use of Nonsteroidal Anti-inflammatory Drugs: A Meta-analysis", J Natl Cancer Inst. 2008 Oct 7. [Epub ahead of print])

Press Releases

Calendar of Events

Images

Infiltrating ductal carcinoma

Stefano Ciatto, - CSPO - Istituto Scientifico Prevenzione Oncologica, Florence, Italy

 

Literature Selection

Comments

  • "Never-smoking nonsmall cell lung cancer as a separate entity" - Tokujiro Yano, Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Kyushu, Japan
     
    "A recent increase of primary lung cancer in never-smokers is prominent in contrast with the decrease of the smoking habit in the advanced countries.  Lung cancer in never-smokers is thus considered an etiologically separate entity from smoking-associated lung cancer. In the present study, the never-smoking non-small cell lung cancer (NSCLC) cohort was characterized by an increased incidence in females, and a higher occurrence of adenocarcinoma, in addition to a better postoperative prognosis in comparison with the smoking NSCLC group.  It was suggested that NSCLC in never-smokers should therefore be considered a separate disease entity.  In consideration of future increase of ‘never-smoking NSCLC’, both clinical trials and investigations should be focused on it"
    (Comment on: 
    Yano T et al.: "Never-smoking nonsmall cell lung cancer as a separate entity: clinicopathologic features and survival", Cancer. 2008 Sep 1;113(5):1012-8)

Press Releases


Literature Selection

Educational Grants - Sincere appreciation is extended to the following companies for their generous support of this activity:
-
Roche
-
AstraZeneca

If this e-mail has reached you in error, simply click on the following link and unsubscribe yourself Unsubscribe

Contact info - For advertising information please contact: A&B@senology.it . For other enquiries, problems or suggestions please contact: staff@senology.it

© A&B Edizioni Medico-Scientifiche - Milan,  Italy.  Fax: +39.035.7171000